second generation HPV E6 targeting TCR-based T-cell therapy (Kite Pharma/bluebird bio)

N/A

ๆŠฅๅ‘Šๆ—ถ้—ด: 2025/03/20 20:00:06

ๅŸบๆœฌไฟกๆฏ

่ฏ็‰ฉๅ็งฐsecond generation HPV E6 targeting TCR-based T-cell therapy (Kite Pharma/bluebird bio)
่ฏ็‰ฉๅˆซ็งฐanti-HPV-16 E6 TCR T-cell therapy (Kite Pharma/bluebird bio)
่ฏ็‰ฉ็ฑปๅž‹็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ้‡็ป„่›‹็™ฝ็ป†่ƒžไธŽๅŸบๅ› ็–—ๆณ• > ็ป†่ƒž็–—ๆณ• > ๅ…็–ซ็ป†่ƒž็–—ๆณ• > ๆท‹ๅทด็ป†่ƒž็–—ๆณ• > T็ป†่ƒž็–—ๆณ•
ไฝœ็”จๆœบๅˆถไบบ็ฑป็™ฝ็ป†่ƒžๆŠ—ๅŽŸ่ฐƒ่Š‚ๅ‰‚E6่›‹็™ฝ่ฐƒ่Š‚ๅ‰‚
้ถ็‚นE6่›‹็™ฝไบบ็ฑป็™ฝ็ป†่ƒžๆŠ—ๅŽŸ
ๆฒป็–—้ข†ๅŸŸ / ้€‚ๅบ”็—‡่‚ฟ็˜ค
ๅ…จ็ƒๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
ไธญๅ›ฝๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
้ฆ–ๆ‰นๅ›ฝๅฎถ/ๅŒบๅŸŸN/A
้ฆ–ๆ‰นๆ—ฅๆœŸN/A
ๅ›ฝๅฎถ/ๅŒบๅŸŸ็พŽๅ›ฝ
ๆ˜ฏๅฆๅคๆ–นๅฆ
ๅ…จ็ƒๆœ€้ซ˜็ ”ๅ‘็Šถๆ€ๆ— ่ฟ›ๅฑ• (ไธดๅบŠๅ‰)
ไธญๅ›ฝๆœ€้ซ˜็ ”ๅ‘็Šถๆ€N/A
ๅŽŸ็ ”ๅ…ฌๅธKite Pharma Inc
ๆณจๅ†Œๅˆ†็ฑปN/A

็ ”ๅ‘ไฟกๆฏ

ๆดป่ทƒๅ…ฌๅธN/A
้žๆดป่ทƒๅ…ฌๅธGenetix Biotherapeutics IncKite Pharma Inc
ๆดป่ทƒ้€‚ๅบ”็—‡N/A
้žๆดป่ทƒ้€‚ๅบ”็—‡่‚ฟ็˜ค

ๅ…ถไป–ไฟกๆฏ

ATCไปฃ็ N/A
็›ธๅ…ณ้“พๆŽฅN/A